Lower-limb deep-vein thrombosis in a general hospital: Risk factors, outcomes and the contribution of intravenous drug use

QJM: An International Journal of Medicine

Volumn 98, Issue 2, 2005, Pages 139-145

  Syed, F F ^a   Beeching, Nicholas J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; GENERAL HOSPITAL; HOSPITAL DISCHARGE; HUMAN; IMMOBILIZATION; INTRAVENOUS ADMINISTRATION; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SURGICAL TECHNIQUE;

EID: 14044268847     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hci020     Document Type: Article

References (25)

1. Heijboer H, Buller HR, Lensing AW, Turpie AG, Colly LP, ten Cate JW. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 1993; 329:1365-9.
2. Luomanmaki K, Grankvist S, Hallert C, Jauro I, Ketola K, Kim HC, Kiviniemi H, Koskivirta H, Sorskog L, Vilkko P. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis. J Intern Med 1996; 240:85-92.
3. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Wed 1997; 337:657-62.
4. Brandjes DP, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW. Randomised trial of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349:759-62.
5. Schulman S, Rhedin A-S, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walters H, Viering S, Nordlander S, Leijd B, Jonsson K-A, Hjorth M, Olle L, Boberg J. A comparison of six weeks with six months of oral anticoagulation therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332:1661-5.
6. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125 1-7.
7. Fox R, Beeching NJ, Morrison C, Ruben S, Garvey T. Misuse of temazepam. Br Med J 1992; 305:253.
8. Killam AL. Cardiovascular and thrombosis pathology associated with cocaine use. Hematol Oncol Clin North Am 1993; 7 1143-51.
9. Lamden KH, Kennedy N, Beeching NJ, Lowe D, Morrison CL, Mallinson H, Mutton KJ, Syed Q. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infection 1998; 37:260-9.
10. Roszler MH, McCarroll KA, Donovan KR, Rashid T, Kling GA. The groin hit: complications of intravenous drug abuse. Radiographics 1989; 9:487-508.
11. Karnofsky DA, Buchenal JH. The clinical evaluation of chemical therapeutic agents in cancer. In: Mackad CM, ed. Evaluation of Chemotherapeutic Agents. New York, Columbia University Press, 1949.
12. Leizorovicz A, Simmonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta analysis. Br Med J 1994; 309:299-304.
13. Lensing AW, Prandoni P, Prins MH, Buller HR. Deep-vein thrombosis. Lancet 1999; 353:479-85.
14. McColl MD, Tait RC, Greer IA, Walker ID. Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol 2001; 112:641-3.
15. Ouriel K, Green RM, Greenberg RK, Clair DG. The anatomy of deep venous thrombosis of the lower extremity. J Vasc Surg 2000; 31:895-900.
16. Lindmarker P, Schulman S, et al. The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg. J Intern Med 2000; 247:601-6.
17. Boccalon H, Elias A, Chale JJ, Cadene A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med 2000; 160:1769-73.
18. Gorman WP, Davis KR, Donnelly R. ABC of arterial and venous disease. Swollen lower limb - 1: general assessment and deep vein thrombosis. Br Med J 2000; 320:1453-6.
19. Kniemeyer HW, Grabitz K, Buhl R, Wust HJ, Sandmann W. Surgical treatment of septic venous thrombosis. Surgery 1995; 118:49-53.
20. Mackenzie AR, Laing RB, Douglas JG, Greaves M, Smith CC. High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J 2000; 76:561-5.
21. Pieper B, Templin T. Chronic venous insufficiency in persons with a history of injection drug use. Res Nurs Health 2001; 24 423-32.
22. Jenkins NF, Syed FF, Beadsworth MB, Nye FJ, Beeching NJ. Deep vein thrombosis in injecting drug users - common but neglected. Unpublished data, 2004.
23. Huber O, Bounaneaux H, Borst F, Rohner A. Post-operative pulmonary embolism after discharge: an underestimated risk. Arch Surg 1992; 127:310-13.
24. Kakkar VV, de Lorenzo F. Prevention of venous thrombo-embolism in general surgery. Baillieres Clin Haematol 1998; 11:605-19.
25. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339:93-104.